New RNA Interference Therapy Promises To Slice High Blood Pressure

Alynlam Pharmaceuticals recently made headlines when they announced the results of a revolutionary RNA interference therapy capable of controlling high blood pressure.

Related Keywords

United States ,American , ,Alnylam Pharmaceuticals ,American Heart Association Conference ,Alynlam Pharamceuticals Inc ,Pharamceuticals Inc ,Heart Association Conference ,Gornai ,Phase 2 ,High Blood Pressure ,Heart Health ,Cardiovascular Health ,Alynlam ,